In our studies both PTEN and MAP3K in hPAECs remained unaffected by pre-incubation of PAH EVs in the presence or absence of miR-486-5p inhibitor or miR-26a-5p mimic (Figure S2). This evidence concerns the gene PTEN and pulmonary arterial hypertension.